Masati Sajady, founder of The XI Code, discusses the unconventional real-world applications of frequency-based recalibration with measurable biological changes.
XI's submission to the XPRIZE faced skepticism over distinguishing its effects from placebos, highlighting a blind spot in modern scientific understanding.
XI Meta Science utilizes time-coded frequencies to restore coherence in multiple body systems, yielding tangible results like telomere lengthening and inflammation reduction.
Sajady criticizes the resistance faced by new discoveries, equating it to historical patterns of dismissal before acceptance.
He challenges existing tools' ability to measure XI's impact effectively and calls for understanding the placebo effect as a significant biological phenomenon.
Sajady questions the XPRIZE committee's reluctance towards unfamiliar ideas, emphasizing the need for integrity in evaluating novel concepts.
He advocates for science to evolve and embrace what it doesn't yet comprehend, positioning XI as a deeper layer of exploration within the scientific framework.
With over 10,000 real-world outcomes challenging conventional norms, Sajady emphasizes the need for reevaluation in how science approaches and validates emerging modalities.
Amidst skepticism and resistance, Sajady underscores the importance of recognizing unconventional breakthroughs that may not fit current scientific paradigms.
The article explores the tension between established scientific norms and the call for a more inclusive and adaptive scientific framework that accommodates novel discoveries.